Operating
Change in Other Liabilities
Pfizer Change in Other Liabilities remained flat by 0.0% to -$916.75M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 17.7%, from -$778.75M to -$916.75M. Over 4 years (FY 2021 to FY 2025), Change in Other Liabilities shows a downward trend with a -33.5% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2025Feb 26, 2026
How to read this metric
An increase suggests the company is deferring obligations or increasing long-term liabilities, providing a source of cash.
Detailed definition
Captures the net change in non-current or miscellaneous liabilities not classified as debt or standard accounts payable....
Peer comparison
Commonly used to track non-operating liability fluctuations across industrial peers.
Metric ID:
change_in_other_liabilitiesHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $18.72B | -$1.45B | $595.00M | -$3.12B | -$3.67B |
| YoY Change | — | -107.7% | +141.1% | -623.5% | -17.7% |
Range-$3.67B – $18.72B
CAGR-33.5%
Avg YoY Growth-152.0%
Median YoY Growth-62.7%
Current Streak2 years decline
Change in Other Liabilities at Other Companies
Frequently Asked Questions
- What is Pfizer's change in other liabilities?
- Pfizer (PFE) reported change in other liabilities of -$916.75M in Q4 2025.
- How has Pfizer's change in other liabilities changed year-over-year?
- Pfizer's change in other liabilities decreased by 17.7% year-over-year, from -$778.75M to -$916.75M.
- What is the long-term trend for Pfizer's change in other liabilities?
- Over 4 years (2021 to 2025), Pfizer's change in other liabilities has grown at a -33.5% compound annual growth rate (CAGR), from $18.72B to -$3.67B.
- What does change in other liabilities mean?
- The net change in miscellaneous long-term or other liabilities.